|
|
Registration / Networking |
|
|
Welcome/
Introduction Moderator: Dr. Li-chung Lee, ITRI,Inc. |
|
|
Opening
Remarks Dr. Ching-Yen Tsai, Minister
without portfolio, Executive Yuan, ROC Dr. Johnsee Lee, President, ITRI, |
|
SESSION 1 |
Theme: Strategies for the Development of Biomedical Industries Moderator: Dr. Yue-Teh Jang, General
Partner, The Vertical Group A
Multi-disciplinary Approach to Building a Successful Medical Device Industry Dr. Paul G..
Yock, M.D., Professor of Medical and Mechanical Engineering, Biotech-The
Rising Star After The High Tech Bubble? Dr. Bryan E. Roberts, General Partner, Venrock Associates Leapfrogging
Strategy for of Biotech Industry in Dr. Frank Kung, Managing General Partner, BioAsia |
|
|
Morning Break |
|
SESSION 2 |
Theme: Striding Toward the Globalization ~ The Present and Future of Moderator—Dr. Ching-Yen Tsai, Minister without portfolio, Executive Yuan, ROC Plenary speakers Government Policies and Strategies on
Biotech Development Dr. Mei-Hsueh Lin, Science and
Technology Advisory Group of Executive Yuan, ROC (tentative) Leveraging Taiwan’s Advantages for Global
Biotech Competitiveness Dr. Johnsee Lee,
President of ITRI
Biotech Partnering Strategies – from Dr. Jui-Lien Huang, President of DCB Mr. David Liu, Vice President of TAITRA |
|
|
Lunch , Networking & Exhibition |
|
SESSION 3 |
Theme: Building a Successful Global Biomedical Industry Moderator: Dr. Kenneth Fong, Chairman, Kenson Ventures,
LLC. Bridging the ‘ Dr. Glenn Rice, VP, Biosciences Division,
SRI International Diagnostics for the Real WorldDr. Helen H. Lee, President & CEO,
Diagnostics for the Real World, Ltd. Accelerating
Development of Dr. Ming-Chu Hsu, President & CEO,
TaiGen Biotechnology Company Ltd. From
Product Concept To The Market Leader Dr. Karen Talmadge, Executive VP&
CSO, Kyphon Inc. |
|
|
Afternoon Break |
|
SESSION 4 |
Panel Discussion: Critical
Issues of Cross-Pacific Business Moderator: Dr. Yue-Teh Jang, General Partner, The
Vertical Group Panelist: Dr. Johnsee
Lee, President, Dr. KeeLung Hong, Founder and
CTO, Hermes Biotech Dr. Por Lai, President,
President David Saul, J.D., Partner, Wilson Sonsini Goodrich & Rosati Dr. Tony Chou, M.D., General Manager, Abbott Laboratories |
|
|
Adjourn |